Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
Mon Compte
No element in selection

Favoris
Établissements de santé
Contact Abonnez-vous aux actualités

0 result

Active substance : spironolactone

Filter

Topic

Diagnostic and therapeutic techniques (2)
Plus ...
Diseases and conditions (2)
Plus ...
Population groups (1)
Plus ...
- Geriatrics (1)

Content type

Practice Guidelines and Other Guides (2)
Plus ...
Drugs, devices and medical acts (1)
Plus ...
- Opinions on products and services (1)

Manufacturer

industriels (1)
RESMED SAS FRANCE (1)

Language

Français (3)

Active substance

alcool (1)
aluminium (1)
amitriptyline (1)
apixaban (1)
arginine (1)
aspirine (1)
biotine (1)
cibenzoline (1)
cilazapril (1)
colchicine (1)
cuivre (1)
cyclophosphamide (1)
digoxine (1)
disopyramide (1)
fer (1)
fluconazole (1)
fosinopril (1)
glutamine (1)
lithium (2)
losartan (1)
lysine (1)
ornithine (1)
potassium (2)
proline (1)
pyridoxine (1)
quinidine (1)
ramipril (1)
rivaroxaban (1)
spironolactone (3)
sulfate de zinc (1)
thiamine (1)
trastuzumab (1)
tyrosine (1)
zinc (1)

More filter Other Filter Icon

Search Export

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

T39gaBaevkRkup3W

You do not have a saved search

No element in selection

0 result

Follow us :